若生智能
Drug Database
IB

ibuprofen (ibuprofen, OSAT / OSAT ibuprofen)

✓ Approved

Paion · PTGS1 · 小分子

什么是 ibuprofen？

ibuprofen 是一种小分子，由Paion研发。该药已获批，用于治疗相关适应症，给药途径：Oral (PO)。

药物档案

商品名ibuprofen, OSAT, OSAT ibuprofen
公司Paion
药物类别小分子
分子靶点PTGS1, PTGS2
给药途径Oral (PO)
状态Approved
来源： ClinicalTrials.gov, Paion

作用机制

分子靶点

ibuprofen 作用于 2 个分子靶点：

PTGS1prostaglandin-endoperoxide synthase 1 (COX3, PCOX1)
PTGS2prostaglandin-endoperoxide synthase 2 (GRIPGHS, hCox-2)
需要更深入的分析？Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

ibuprofen 针对 3 个适应症，涉及 1 个治疗领域。

治疗领域疾病/病症分期
Musculoskeletal and connective tissue disordersMusculoskeletal pain✓ Approved
Musculoskeletal and connective tissue disordersMyositis✓ Approved
Musculoskeletal and connective tissue disordersRheumatoid arthritis✓ Approved

相关研究文献

PubMedCardiology in the young2026-08-05

Minimising an outpatient medication regimen after paediatric cardiac surgery.

Penk Jamie Smith JS, Jackson Lindsay L, Baptista de Faria Guilherme G, Doyle Laura L et al.

We implemented a quality improvement initiative to optimise the outpatient medication regimen after paediatric cardiac surgery. A previous trial that limited furosemide found no readmissions for pleural effusion but an increase in pericardial effusions. A similar quality improvement project had implemented prophylactic non-steroidal anti-inflammatory drugs and found a decrease in readmissions for pericardial effusion. We used these results to design an outpatient medication regimen that minimises furosemide and uses only targeted ibuprofen and report readmission rates from this project. Single-centre analysis of outcomes since the adoption of a quality improvement initiative aiming to limit outpatient diuretics (≤5 days) while using targeted ibuprofen to prevent pericardial effusion readmissions. Two hundred and one patients were eligible for analysis. Forty-one patients (20.4%) were prescribed >20 days of diuretics due to compliance failure and were not considered to have received a limited diuretic regimen, leaving 160 patients. Of those, 53 (33.1%) were correctly prescribed targeted ibuprofen based on meeting "high-risk" criteria. There was one readmission for pleural effusion and 2/160 (1.3%) readmissions for pericardial effusion. The previous prospective study of limited furosemide without ibuprofen had a pericardial effusion readmission rate of 4/61 (6.6%) versus the 2/160 (1.3%) after implementing the regimen described in this report (p = 0.04). We describe a medication regimen using limited outpatient furosemide without increased readmissions for pleural effusions. Targeted ibuprofen was used for high-risk patients only, and there were fewer readmissions for pericardial effusions than in a previous trial that used furosemide alone.

PMID 42553008
阅读全文 →
PubMedHIV/AIDS (Auckland, N.Z.)2026-08-05

From Denial to Near Blindness: Overcoming Herpes Zoster Ophthalmicus in a Rural Ugandan Man with HIV and Alcoholism.

Okongo Benson B, Amuge Gladys G, Adong Ruth Lucy RL, Okengo Anthony O AO et al.

In remote Ugandan settings, HIV care retention remains poor among men and pastoralists. Despite progress toward UNAIDS 95-95-95 targets, structural barriers, geographic isolation and stigma continue to undermine long-term retention. In 2022, a male pastoralist in his early forties with heavy alcohol use presented to a rural health center in Karamoja with fever and weight loss, and was diagnosed with HIV. He declined antiretroviral therapy (ART) believing the drugs were "poisonous" and was lost to follow-up for 48 months. He re-presented in March 2026 with a one-year history of a scaly, pruritic lesion on his right hand extending to the face and neck, unresponsive to antifungal creams. Two days prior, he developed an acutely painful vesicular eruption in the right V1 trigeminal distribution, along with oropharyngeal candidiasis. CD4 count was 120 cells/μL and urine TB LAM was positive, indicating disseminated tuberculosis. While LAM is highly suggestive and warrants immediate empirical treatment, definitive diagnosis of dissemination ideally requires clinical and radiological correlation. He was treated with oral acyclovir (800 mg five times daily for 10 days), topical acyclovir, ibuprofen, intensive-phase anti-TB therapy, and fluconazole (200 mg daily for 14 days). ART was deferred for two weeks to manage acute opportunistic infections and monitor for IRIS. At two weeks, the zoster lesions had crusted, oral candidiasis cleared, and pain reduced to 2/10. ART was initiated on day 14 with village health team support. At three months, he remained adherent with no new opportunistic infections. Delayed ART initiation caused years of preventable suffering. This case highlights the urgent need in low-income settings for community re-engagement strategies, integrated HIV/co-infection screening, point-of-care diagnostics, and culturally tailored care. As the patient stated: "I was sick, and now I am well. The science of HIV treatment is a miracle, and I am living proof.".

PMID 42553801
阅读全文 →
PubMedInternational journal of pharmaceutics2026-08-04

Predictive compaction modelling of ternary direct compression formulations.

Tait Theo T, Salehian Mohammad M, Aroniada Magdalini M, Shier Andrew P AP et al.

Developing directly-compressed formulations remains a resource-intensive task, requiring substantial experimental effort to characterise the compressibility and compactability of a formulation space. This study extends a global optimisation of mixture rules to a ternary formulation space (API-brittle filler-elastic filler) and investigates the potential for reducing experimental burden whilst maintaining the predictive accuracy of empirical compression and compaction models. Three grades each of paracetamol and ibuprofen, combined with a consistent placebo base, were used to evaluate the approach. The global optimisation outperformed the traditional line of best fit approach, achieving strong predictive performance for the Kawakita model (R2>0.94; RMSE<0.01) and more variable fits for the Ryshkewitch-Duckworth model (R2 = 0.93 - 0.95 and RMSE = 0.23 - 0.39 MPa for paracetamol; R2 = 0.70 - 0.83 and RMSE = 0.31 - 0.37 MPa for ibuprofen). The optimisations performance was found to improve when the training dataset considered only drug-loaded blends. The exploration of reducing experimental burden considered a Model-Based Design of Experiments (MBDoE) which was benchmarked against random experiment selection. Integrating MBDoE with optimised mixture rules reduced API consumption by over 30% across all formulations, with median savings of 75%-95% under Acceptable and Good performance thresholds. Savings decreased with increasing threshold stringency, with the greatest variability observed in ibuprofen formulations. The Kawakita model supported reductions across all threshold levels, whilst the Ryshkewitch-Duckworth model showed limited capacity beyond the Acceptable threshold. tThe MBDoE did not outperform the random selection of experiments, however the optimisation framework for populating empirical compression and compaction models offers a resource-efficient approach to predicting tablet porosity and tensile strength of ternary API loaded blends.

PMID 42546992
阅读全文 →
PubMedPharmaceutical research2026-08-04

Domain Knowledge Constrained Symbolic Regression for Optimising Dermal Drug Formulations.

Zhang Yu Y, Wang Xilu X, Tsaoulidis Dimitrios D, Chen Tao T

Interpretable dynamic models that remain physically admissible under extrapolation are essential for dermal formulation optimisation. Mechanistic models are often labour-intensive to derive, whereas unconstrained data-driven models may violate physical constraints and degrade beyond observed conditions. We developed a domain knowledge constrained symbolic regression (DKC-SR) framework to discover compact, interpretable dynamic models for cumulative release directly from time-series experiments. Domain knowledge was embedded through a restricted operator set and feasibility constraints over the bounded optimisation domain. Candidate expressions were evaluated by numerically solving the dynamic differential equations and selected using an information-criterion trade-off across a level-wise set of complexity-controlled models. The final surrogate was coupled with the covariance matrix adaptation evolution strategy for formulation optimisation. In an ibuprofen formulation case study, the selected model provided a formulation ranking that, combined with experimental validation, guided the optimiser to a narrow high-performing region; a representative optimum was experimentally confirmed to exceed the historical best. Although the surrogate was more reliable for ranking and optimisation guidance than for exact quantitative calibration, it remained physically admissible and numerically stable across the design space. DKC-SR provides a compact, interpretable, and optimisation-ready route to modelling dermal release under bounded design constraints.

PMID 42547741
阅读全文 →
PubMedThe Linacre quarterly2026-08-02

Catholic Doctrine Supports Religious Exemption to COVID-19 Vaccine Mandates.

McKenna Kyle C KC, McGovern Curt C, Sabol Meredith M

Recent federal court cases involving termination of employees who were denied a religious exemption to refuse COVID-19 vaccination mandated by employers renewed the discussion of the morality of using medicines produced and/or tested in cell lines derived from elective abortions. A common argument of employers in these lawsuits was that the association of COVID-19 vaccines and certain over-the-counter (OTC) medicines with past abortions was equivalent. Therefore, the use of OTC medicines but refusal of COVID-19 vaccines represented a contradiction to a sincerely held religious belief. In this commentary, we demonstrate that the association of COVID-19 vaccines and certain OTC drugs (aspirin, ibuprofen, Benadryl, and Claritin) with past abortions is not equivalent. We outline the Catholic church's position on the use of medicines with an association with elective abortions and demonstrate how Catholic doctrine supports religious-exemptions to COVID-19 vaccine mandates citing a tenet of the faith, respect for all human life.

PMID 42539580
阅读全文 →
PubMedThe Science of the total environment2026-08-02

Exposure to pharmaceutical contaminants in stranded wild dolphins of the Western Mediterranean.

Navas Isabel I, Felipo-Benavent Mar M, Crespo-Picazo Jose Luis JL, García-Párraga Daniel D et al.

Pharmaceutical contamination in aquatic ecosystems is a growing concern for marine biodiversity and human health. We have detected six different non-steroideal anti-inflamatory drugs (carprofen, ibuprofen, ketoprofen, phenylbutazone, diclofenac and flunixin), five antibiotics (florfenicol, enrofloxacin, ciprofloxacin, oxytetracycline and trimethoprim), acetaminophen and caffeine in liver samples from 13 bottlenose dolphins (Tursiops truncattus) and 14 striped dolphins (Stenella coeruleoalba) inhabiting the western Mediterranean Sea and stranded in the coast of Valencian Community (Spain) between 2010 and 2024. To our knowledge, this study is the first documentation of some of these pharmaceuticals in wild marine-mammal tissues. Our results confirm the presence of these contaminants in the Mediterranean marine ecosystem and their incorporation into the top predator level, likely mainly through the food chain. These pollutants could cause physiological alterations in exposed individuals and may represent a potential risk for population health and resilience under chronic exposure scenarios. Potential sources of such contamination include domestic wastewater and discharges from large cruise ships, as well as open aquaculture plants, highlighting the need for enhanced monitoring and awareness to mitigate the impact of pharmaceutical contamination in marine mammals and advocate for effectively protecting marine biodiversity and human health.

PMID 42541946
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多ibuprofen